Lynx1 Capital Management Lp Insider Trades

Insider Trading History

Track insider trading activity for Lynx1 Capital Management Lp. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Korro Bio
Korro Bio KRRO
10% owner
Holding Value $17.2M 1,538,296 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.51k 520 shares
$10.60
$11.18
Tscan Therapeutics
Tscan Therapeutics TCRX
10% owner
Holding Value $8.18M 8,019,148 shares
Last Trade
Dec 23, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.61k 6,232 shares
$0.90
$1.02
Tscan Therapeutics
Tscan Therapeutics TCRX
10% owner
Holding Value $8.17M 8,012,916 shares
Last Trade
Dec 22, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$68k 75,500 shares
$0.90
$1.02
Tscan Therapeutics
Tscan Therapeutics TCRX
10% owner
Holding Value $8.1M 7,937,416 shares
Last Trade
Dec 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$72.1k 80,069 shares
$0.90
$1.02
Cullinan Therapeutics
Cullinan Therapeutics CGEM
10% owner
Holding Value $129M 8,963,500 shares
Last Trade
Oct 28, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.39M 165,667 shares
$8.40
$14.43
Cullinan Therapeutics
Cullinan Therapeutics CGEM
10% owner
Holding Value $127M 8,797,833 shares
Last Trade
Oct 17, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$253k 32,217 shares
$7.84
$14.43
Cullinan Therapeutics
Cullinan Therapeutics CGEM
10% owner
Holding Value $126M 8,765,616 shares
Last Trade
Oct 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.33M 150,000 shares
$8.86
$14.43
Cullinan Therapeutics
Cullinan Therapeutics CGEM
10% owner
Holding Value $124M 8,615,616 shares
Last Trade
Oct 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$409k 51,500 shares
$7.94
$14.43
Cullinan Therapeutics
Cullinan Therapeutics CGEM
10% owner
Holding Value $124M 8,564,116 shares
Last Trade
Oct 14, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$114k 15,032 shares
$7.59
$14.43
Cullinan Therapeutics
Cullinan Therapeutics CGEM
10% owner
Holding Value $123M 8,549,084 shares
Last Trade
Oct 10, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.04M 277,298 shares
$7.36
$14.43
Cullinan Therapeutics
Cullinan Therapeutics CGEM
10% owner
Holding Value $119M 8,271,786 shares
Last Trade
Oct 09, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.19M 626,043 shares
$6.70
$14.43
Cullinan Therapeutics
Cullinan Therapeutics CGEM
10% owner
Holding Value $110M 7,645,743 shares
Last Trade
Oct 08, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.59M 556,300 shares
$6.46
$14.43
Passage Bio
Passage Bio PASG
10% owner
Holding Value $3.74M 623,704 shares
Last Trade
Sep 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$83.2k 11,900 shares
$6.99
$6.00
Passage Bio
Passage Bio PASG
10% owner
Holding Value $3.67M 611,804 shares
Last Trade
Sep 12, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$138k 19,783 shares
$6.99
$6.00
Passage Bio
Passage Bio PASG
10% owner
Holding Value $3.55M 592,021 shares
Last Trade
Sep 11, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.26k 325 shares
$6.96
$6.00
Passage Bio
Passage Bio PASG
10% owner
Holding Value $3.55M 591,696 shares
Last Trade
Jul 24, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$379k 66,423 shares
$5.71
$6.00
Passage Bio
Passage Bio PASG
10% owner
Holding Value $3.15M 525,273 shares
Last Trade
Jul 23, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$283k 49,302 shares
$5.74
$6.00
Passage Bio
Passage Bio PASG
10% owner
Holding Value $2.86M 475,971 shares
Last Trade
Jul 22, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$71.4k 13,123 shares
$5.44
$6.00
Tscan Therapeutics
Tscan Therapeutics TCRX
10% owner
Holding Value $8.11M 7,946,141 shares
Last Trade
May 20, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.44M 1,200,000 shares
$1.20
$1.02
Tscan Therapeutics
Tscan Therapeutics TCRX
10% owner
Holding Value $6.88M 6,746,141 shares
Last Trade
May 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.67M 1,388,794 shares
$1.20
$1.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up